-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Nascent Biotech Inc. quarterly/annual General and Administrative Expense history and growth rate from Q2 2017 to Q2 2024.
- Nascent Biotech Inc. General and Administrative Expense for the quarter ending June 30, 2024 was $106K, a 20.9% increase year-over-year.
- Nascent Biotech Inc. General and Administrative Expense for the twelve months ending June 30, 2024 was $422K, a 10.1% increase year-over-year.
- Nascent Biotech Inc. annual General and Administrative Expense for 2023 was $404K, a 0.42% decline from 2022.
- Nascent Biotech Inc. annual General and Administrative Expense for 2022 was $405K, a 6.82% increase from 2021.
- Nascent Biotech Inc. annual General and Administrative Expense for 2021 was $379K, a 5.61% increase from 2020.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)